+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc. - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapeutics - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Nasal Polyposis Treatment - Global Strategic Business Report - Product Thumbnail Image

Nasal Polyposis Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 382 Pages
  • Global
From
Cystic Fibrosis Devices - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Devices - Global Strategic Business Report

  • Report
  • November 2026
  • 93 Pages
  • Global
From
Bispecific Antibodies Market Size, Share & Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune disorders), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2023-2030 - Product Thumbnail Image

Bispecific Antibodies Market Size, Share & Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune disorders), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2023-2030

  • Report
  • June 2023
  • 120 Pages
  • Global
From
Acute Ischemic Stroke Diagnosis and Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Acute Ischemic Stroke Diagnosis and Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 176 Pages
  • Global
From
Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region - Product Thumbnail Image

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Herceptin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Thumbnail Image

Herceptin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • April 2025
  • 135 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2026

  • Report
  • October 2026
  • 550 Pages
  • Global
From
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026 - Product Thumbnail Image

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026

  • Report
  • September 2026
  • 650 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region - Product Thumbnail Image

Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 111 Pages
  • Global
From
Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 696 Pages
  • Global
From
GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 - Product Thumbnail Image

GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030

  • Report
  • December 2024
  • 840 Pages
  • Middle East
From
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026 - Product Thumbnail Image

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026

  • Report
  • September 2026
  • 550 Pages
  • Global
From
Immunotoxins Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Immunotoxins Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • October 2024
  • 94 Pages
  • Global
From
Novel Ocular Drug Delivery Devices Market: Focus on Implants, Inserts and Punctal Plugs - Distribution by Type of Drug Delivery Device, Target Indications, Type of Product and Key Geographies: Industry Trends and Global Forecast, 2021-2030 - Product Thumbnail Image

Novel Ocular Drug Delivery Devices Market: Focus on Implants, Inserts and Punctal Plugs - Distribution by Type of Drug Delivery Device, Target Indications, Type of Product and Key Geographies: Industry Trends and Global Forecast, 2021-2030

  • Report
  • September 2021
  • 201 Pages
  • Global
From
Chronic Hives Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Chronic Hives Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 116 Pages
  • Global
From
Bleeding Disorder Drugs - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorder Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 488 Pages
  • Global
From
Tissue Plasminogen Activators - Global Strategic Business Report - Product Thumbnail Image

Tissue Plasminogen Activators - Global Strategic Business Report

  • Report
  • November 2026
  • 280 Pages
  • Global
From
Loading Indicator